In Russia began to use a new vaccine against colon cancer
In Russia started a pilot stage of the drug to combat colorectal cancer

In Russia, the pilot stage of the use of the drug to combat colorectal cancer began. According to Igor Borisevich, deputy head of the Federal Medical and Biological Agency (FMBA), currently there is a selection of volunteers for treatment.
This vaccine, which has already received official approval, is made individually for each patient, using as a basis the neoantigens characteristic of his tumor cells. Therapy is designed for an adult group of patients who have previously undergone surgery and have undergone at least two courses of systemic chemotherapy.
The first injections of the drug were made in March. The head of FMBA Veronika Skvortsova noted that initial observations indicate good tolerability of the drug, the absence of serious adverse reactions and the formation of the expected immune response.



